• Polygodial Workflows for TRPA1 Channel Research

  2026-09-05

  Polygodial provides a practical chemical activation arm for linking TRPA1 ion channel activity to calcium signaling, NFAT localization, and epithelial inflammatory outputs. This workflow emphasizes fresh DMSO preparation, rapid calcium measurements, orthogonal controls, and troubleshooting steps for sensory biology and neurophysiology research.

• N2703 in Neuro-Cardiac Signaling Assays

  2026-09-04

  Use 3-(1-methylpyrrolidin-2-yl)pyridine (N2703) as a solvent-flexible exploratory perturbant in neuron–cardiomyocyte–adipocyte assays. This workflow emphasizes fresh solution preparation, matched vehicle controls, electrophysiology, and mechanistic follow-up rather than assuming a predefined molecular target.

• Protein A/G Magnetic Co-IP/IP Kit Guide

  2026-09-04

  A scenario-based guide to improving protein-complex isolation alongside viability, proliferation, and cytotoxicity studies. It explains how Protein A/G Magnetic Co-IP/IP Kit SKU K1309 supports reproducible magnetic immunoprecipitation, compatibility testing, protocol optimization, and evidence-based vendor selection.

• AL-8810 for FP Receptor Signaling Research

  2026-09-03

  AL-8810 is a selective prostaglandin F2α antagonist for separating FP receptor activity from upstream prostanoid production. This practical guide connects concentration–response assays with endometrial breakdown, vascular permeability, smooth muscle signaling, ERK1/2 activation, and MMP-2 secretion.

• IWP-L6: Precision Porcupine Inhibition Workflows

  2026-09-03

  IWP-L6 enables controlled Wnt signaling modulation from cell-based target-engagement assays to zebrafish regeneration and embryonic kidney models. This application-focused guide connects Porcn enzyme inhibition with metabolic and osteogenic readouts while emphasizing dose selection, controls, and troubleshooting.

• Sildenafil Citrate and Proteoform-Precision Vascular Biology

  2026-09-02

  Sildenafil Citrate is more than a conventional PDE5 tool: it provides a tractable entry point for connecting cGMP biology, vascular phenotypes, ERK signaling, and proteoform-resolved drug selectivity. This translational framework shows how researchers can move from potency measurements toward native-environment evidence that better anticipates efficacy and off-target behavior.

• DIDS in Chloride and Tumor-State Research

  2026-09-02

  DIDS combines practical chloride-transport perturbation with a powerful workflow for studying cells that survive impending death. This guide connects concentration planning, formulation, ion-channel assays, and PAME-focused tumor experiments while emphasizing controls and interpretation limits.

• QSHXO in MASLD: Autophagy and Ferroptosis

  2026-09-01

  Liu et al. show that Qushi Huoxue ointment improves hepatic steatosis and inflammation in a mouse model of metabolic associated steatotic liver disease by coordinating autophagy activation with ferroptosis suppression. The study combines phenotypic, molecular, computational, and ultrastructural analyses, offering a mechanistic framework for designing follow-up MASLD experiments.

• (S)-(+)-Ibuprofen: A Smarter Assay Design Framework

  2026-09-01

  Explore how (S)-(+)-Ibuprofen can improve COX inhibitor experiments through stereochemical controls, concentration-aware assay design, and environmental exposure analysis. This evidence-led framework connects prostaglandin biology with practical decisions about reproducibility and interpretation.

• Macromolecular Cryoprotectants Improve THP-1 Banking

  2026-08-31

  A 2025 RSC Applied Polymers study shows that polyampholyte-based macromolecular cryoprotectants, combined with controlled ice nucleation, improve post-thaw recovery and macrophage differentiation of THP-1 cells in both vials and multi-well plates. Cryo-Raman imaging links this performance to reduced intracellular ice formation, supporting more consistent assay-ready immune-cell workflows.

• CX-4945: Applied CK2 Inhibition in Lung Cancer

  2026-08-31

  CX-4945 (Silmitasertib) enables time-controlled CK2 inhibition for dissecting signaling, apoptosis, cell-cycle behavior, and cisplatin resistance in cancer models. This workflow connects pathway-level pharmacology with the ECE-1c-driven aggressiveness described in recent NSCLC research.

• Nicotine Signaling in Chronic Kidney Disease Progression

  2026-08-30

  Jain and Jaimes integrate clinical and experimental evidence showing that nicotine may directly accelerate chronic kidney disease through non-neuronal nicotinic acetylcholine receptors, oxidative stress, hemodynamic changes, and pro-fibrotic signaling. The review’s main practical contribution is a mechanistic framework for connecting smoking exposure with renal injury across diabetes, hypertension, transplantation, and other CKD settings.

• HOXB4, BMSCs, and Wnt Signaling in Acute Lung Injury

  2026-08-29

  Lin et al. show that HOXB4-overexpressing bone marrow mesenchymal stem cells protect lipopolysaccharide-injured endothelial cells more effectively than unmodified BMSCs. Their transwell coculture and XAV-939 inhibition experiments connect this benefit partly to restoration of Wnt/β-catenin signaling, while also highlighting the need for in vivo validation.

• GW4064 Workflows for FXR Metabolic Research

  2026-08-28

  GW4064 is a selective, non-steroidal FXR agonist for separating receptor activation from complex bile acid and lipid exposures. This guide translates its use into reporter, hepatocyte, LX-2 fibrosis, and FXR/TLR4/ferroptosis workflows, with practical formulation and troubleshooting guidance.

• Nuclear cGAS, CHK2, and L1 Retrotransposition

  2026-08-28

  The reference study identifies a nuclear genome-protection pathway in which CHK2-phosphorylated cGAS promotes TRIM41-dependent ubiquitination and degradation of L1 ORF2p, thereby limiting LINE-1 retrotransposition. Its findings connect DNA damage signaling with posttranslational control of mobile genetic elements and provide a mechanistic framework relevant to genome stability, cellular senescence, and cancer research.

8537 records 1/570 page Next 12345 下5页 Last page